Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NovaBay Pharmaceuticals Inc NBY

NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NYSEAM:NBY)

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Business Wire 14 hours ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Business Wire 3 days ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Business Wire March 26, 2024

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Business Wire March 25, 2024

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Business Wire March 14, 2024

NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals

GlobeNewswire March 13, 2024

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Business Wire January 30, 2024

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

Business Wire January 9, 2024

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Business Wire December 6, 2023

Bullboard Posts (NYSEAM:NBY)

Real stock price share value

5.25$
Nibinator - November 15, 2023

I m very conservative on that 150%

Looking for 300%
Nibinator - October 28, 2023

Who wants to make 150 % in 2 weeks

Me
Nibinator - October 28, 2023

15 november that will hit

0.85 easy
Nibinator - October 28, 2023

Real stock price share value

12$
Nibinator - October 28, 2023

NBY.....don't even think about it !!!

I really don't trust this Maddapakka !!!!
Iseneschal - September 22, 2023